Patient Guide: A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 23 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04782258
Status: 🟢 Enrolling Now
Condition: Autosomal Recessive Polycystic Kidney (ARPKD)
Phase: PHASE3

Where You Can Participate

This study is available at 23 locations across the country.

Top locations include:
  • • Washington, District of Columbia
  • • Atlanta, Georgia
  • • Chicago, Illinois
  • • And 20 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD) - Join Clinical Trial NCTNCT04782258

How to Join This Clinical Trial - NCTNCT04782258

Learn how to participate in this PHASE3 trial studying an investigational therapy for Autosomal Recessive Polycystic Kidney (ARPKD). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Autosomal Recessive Polycystic Kidney (ARPKD). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Autosomal Recessive Polycystic Kidney (ARPKD)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04782258 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 23 locations. Find a study site near you:

Clinical Research Site

Washington, District of Columbia 20010 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: RECRUITING

Clinical Research Site

Indianapolis, Indiana 46202-5119 - United States

Status: WITHDRAWN

Clinical Research Site

New Orleans, Louisiana 70118 - United States

Status: WITHDRAWN

Clinical Research Site

Baltimore, Maryland 21287 - United States

Status: RECRUITING

Clinical Research Site

Ann Arbor, Michigan 48109-5000 - United States

Status: RECRUITING

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: RECRUITING

Clinical Research Site

Cincinnati, Ohio 45229-3039 - United States

Status: RECRUITING

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: RECRUITING

And 13 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Autosomal Recessive Polycystic Kidney (ARPKD):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships